Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 3.2900 |
| Open | 3.3000 |
| Bid | 3.1900 x 0 |
| Ask | 3.2100 x 0 |
| Day's Range | 3.1900 - 3.4400 |
| 52 Week Range | 1.0100 - 3.4500 |
| Volume | 134,143 |
| Avg. Volume | 81,898 |
| Market Cap | 266.885M |
| Beta (5Y Monthly) | 0.99 |
| PE Ratio (TTM) | 53.33 |
| EPS (TTM) | 0.0600 |
| Earnings Date | Nov 11, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.95 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- CNW Group
Equiton Capital Inc. Announces Team Expansion
Equiton has added David Frei, CFA as Executive Vice President, National Sales and Client Solutions. TORONTO, Jan.
- CNW Group
5N Plus Expands its Active Pharmaceutical Ingredient (API) Portfolio to Include Compounds for a New Class of Antibiotic & Antibiofilm Drugs
MONTREAL, Jan. 12, 2021 /CNW/ -Â 5N Plus Inc.
- CNW Group
5N Plus Acquires Stake in Microbion and Secures Drug Substance Manufacturing Rights
MONTREAL and BOZEMAN, Mont., Jan.
© 2021 Verizon Media. All rights reserved.
